News
Sarepta Therapeutics (SRPT) stock is in focus after the US Food and Drug Administration (FDA) asked the company to halt ...
Stocks were rising Monday as Wall Street monitored the latest trade developments, digested a number of earnings reports, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results